Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells

Human Gene Therapy

Volumn 11, Issue 14, 2000, Pages 1997-2008

  Perricone, M A ^a   Rees, D D ^b   Sacks, C R ^a   Smith, K A ^a   Kaplan, J M ^a   St George, J A ^a  

^a GENZYME CORPORATION   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEINASE INHIBITOR; VIRUS ANTIBODY;

ADENOVIRUS; ADSORPTION; ADULT; ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CYSTIC FIBROSIS; CYTOTOXICITY; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSFECTION; HEAT TREATMENT; HUMAN; HUMAN CELL; NONHUMAN; RESPIRATORY EPITHELIUM; SPUTUM;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; BRONCHI; CATHEPSINS; CELLS, CULTURED; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKOCYTE ELASTASE; PROTEASE INHIBITORS; RATS; SERINE ENDOPEPTIDASES; SPUTUM; TEMPERATURE; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; ULTRACENTRIFUGATION;

ADENOVIRIDAE; ANIMALIA; MARTES PENNANTI;

EID: 0034692461     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050143426     Document Type: Article

References (38)

1. Characterization of an adenovirus gene transfer vector containing an E4 deletion
2. Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid
3. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups
4. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial
5. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis
6. Immune responses to adenovirus and adeno-associated virus in humans
7. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
8. Gene therapy approaches for inherited and acquired lung diseases
9. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vecto
10. Immune response to recombinant capsid proteins of adenovirus in humans: Antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity
11. Adenovirus aggregation and preservation in extracellular environment
12. Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes
13. Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: Implications for gene therapy of cystic fibrosis
14. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans
15. Cellular immune responses of healthy individuals to intradermal administration of an E1-E3- adenovirus gene transfer vector
16. Molecular characterization of replication-competant variants of adenoviral vectors and genome modifications to prevent their occurrence
17. Host immune responses to recombinant adenoviral vectors
18. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium
19. Pre-treatment with elastase improves the efficiency of percutaneous adenovirus-mediated gene transfer to the arterial media
20. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer
21. Distribution of DNA and alginate in purulent cystic fibrosis sputum: Implications to pulmonary targeting strategies
22. Instability of adenoviral vectors during transport and its implication for clinical studies
23. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo
24. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer
25. Role of CFTR in airway disease
26. Effects of cystic fibrosis airway secretions on rat lung: Role of neutrophil elastase
27. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
28. Circumvention of immunity to the adenovirus major coat protein hexon
29. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis
30. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro
31. Effects of bronchopulmonary inflammation induced by Pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice
32. Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice
33. Gene therapy for cystic fibrosis: Challenges and future directions
34. Twelve-month improvement of pulmonary function in cystic fibrosis patients using aerosolized dornase alfa
35. Adenovirus-mediated gene transfer for cystic fibrosis: Quantitative evaluation of repeated in vivo vector administration to the lung
36. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
37. Repeat administration of an adenovirus vector encoding cystis fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis
38. Glycophosphatidylinositol-anchored proteins are preferentially targeted to the basolateral surface in Fisher rat thyroid epithelial cells